ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Vor Biopharma Inc

Vor Biopharma Inc (VOR)

1.27
0.43
(51.55%)
Cerrado 27 Diciembre 3:00PM
1.22
-0.05
( -3.94% )
Pre Mercado: 6:22AM

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
1.22
Postura de Compra
1.17
Postura de Venta
1.24
Volume Operado de la Acción
57,236
0.00 Rango del Día 0.00
0.6354 Rango de 52 semanas 3.1399
Capitalización de Mercado [m]
Precio Anterior
1.27
Precio de Apertura
-
Última hora de negociación
06:22:58
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
632,204
Acciones en circulación
68,673,612
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.74
Beneficio por acción (BPA)
-1.72
turnover
-
Beneficio neto
-117.86M

Acerca de Vor Biopharma Inc

Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33. Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.

Sector
Biological Pds,ex Diagnstics
Industria
Biological Pds,ex Diagnstics
Sitio web
Sede
Wilmington, Delaware, USA
Fundado
-
Vor Biopharma Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker VOR. The last closing price for Vor Biopharma was US$1.27. Over the last year, Vor Biopharma shares have traded in a share price range of US$ 0.6354 to US$ 3.1399.

Vor Biopharma currently has 68,673,612 shares in issue. The market capitalisation of Vor Biopharma is US$87.22 million. Vor Biopharma has a price to earnings ratio (PE ratio) of -0.74.

VOR Últimas noticias

Vor Bio Announces $55.6 Million Private Placement

Intend to announce updated clinical data from Phase 1/2 VBP301 trial of VCAR33ALLO in the first half of 2025 and updated clinical data from Phase 1/2a VBP101 trial of trem-cel in combination with...

Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial Design

Preliminary data suggests improved relapse-free survival compared to published groups of acute myeloid leukemia (AML) patients at high risk of relapse post-transplantTrem-cel + Mylotarg continue...

Vor Bio to Participate in the Stifel 2024 Healthcare Conference

CAMBRIDGE, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in a fireside chat and...

Vor Bio Reports Third Quarter 2024 Financial Results and Provides Company Update

Company to present trem-cel + Mylotarg clinical data update at American Society of Hematology (ASH) 2024 annual meetingHan Choi, M.D., LL.M, seasoned healthcare institutional investor, appointed...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.36943.36075205640.8511.620.819218831501.22286373CS
40.3743.52941176470.851.620.88980851.07999337CS
120.5479.41176470590.681.620.63546322040.92975289CS
260.1918.44660194171.031.620.63547041830.9130393CS
52-1.03-45.77777777782.253.13990.63545168241.18450615CS
156-10.45-89.545844044611.6712.730.63542619252.43875258CS
260-40.8-97.096620656842.0263.620.63542398716.29085048CS

VOR - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Vor Biopharma?
El precio actual de las acciones de Vor Biopharma es US$ 1.22
¿Cuántas acciones de Vor Biopharma están en circulación?
Vor Biopharma tiene 68,673,612 acciones en circulación
¿Cuál es la capitalización de mercado de Vor Biopharma?
La capitalización de mercado de Vor Biopharma es USD 87.22M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Vor Biopharma?
Vor Biopharma ha negociado en un rango de US$ 0.6354 a US$ 3.1399 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Vor Biopharma?
El ratio precio/beneficio de Vor Biopharma es -0.74
¿Cuál es la moneda de reporte de Vor Biopharma?
Vor Biopharma presenta sus resultados financieros en USD
¿Cuál es el último beneficio anual de Vor Biopharma?
El último beneficio anual de Vor Biopharma es USD -117.86M
¿Cuál es la dirección registrada de Vor Biopharma?
La dirección registrada de Vor Biopharma es 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
¿Cuál es la dirección del sitio web de Vor Biopharma?
La dirección del sitio web de Vor Biopharma es www.vorbio.com
¿En qué sector industrial opera Vor Biopharma?
Vor Biopharma opera en el sector BIOLOGICAL PDS,EX DIAGNSTICS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
WATTEnergous Corporation
US$ 1.53
(272.08%)
43.17M
NXUNXU Inc
US$ 0.5325
(118.78%)
31.04M
INTZIntrusion Inc
US$ 4.189
(93.94%)
19.71M
PLRZPolyrizon Ltd
US$ 2.93
(78.66%)
6.51M
VINCVincerx Inc
US$ 0.2939
(51.49%)
16.35M
LITMSnow Lake Resources Ltd
US$ 1.01
(-36.88%)
7.22M
HUBCWHub Cyber Security Ltd
US$ 0.0256
(-26.86%)
104.31k
RPAYRepay Holdings Corporation
US$ 6.01
(-22.35%)
1
LINCLincoln Educational Services Corp
US$ 12.01
(-22.11%)
11
YHGJYunhong CTI Ltd
US$ 0.403
(-20.98%)
1
WATTEnergous Corporation
US$ 1.53
(272.08%)
43.17M
NXUNXU Inc
US$ 0.5325
(118.78%)
31.04M
INTZIntrusion Inc
US$ 4.189
(93.94%)
19.71M
SMXSMX Security Matters Public Company
US$ 0.4751
(34.36%)
18.85M
VINCVincerx Inc
US$ 0.2939
(51.49%)
16.35M

VOR Discussion

Ver más
PonkenPlonken PonkenPlonken 3 días hace
close above 200??
👍️0
PonkenPlonken PonkenPlonken 3 días hace
Money goes where its treated best.... now imagine what the stock can do on actual data
👍️0
PonkenPlonken PonkenPlonken 3 días hace
not bad
still looking for a VINC move! waiting for the unveil
👍️0
PonkenPlonken PonkenPlonken 3 días hace
GOOD stuff - remember traded at .8s last weeks

Vor Bio will issue an aggregate of 55,871,260 shares of common stock and accompanying warrants to purchase an aggregate of 69,839,075 shares of common stock at a combined price of $0.99425 per share and accompanying warrants. The warrants will have a per share exercise price of $0.838 and may be exercised at any time on or after the closing date and through the seventh anniversary of the closing date
https://www.globenewswire.com/news-release/2024/12/27/3002259/0/en/Vor-Bio-Announces-55-6-Million-Private-Placement.html
👍️0
PonkenPlonken PonkenPlonken 2 semanas hace
beam me up scotty
👍️0
PonkenPlonken PonkenPlonken 2 semanas hace
readying here
👍️0
PonkenPlonken PonkenPlonken 2 meses hace
VINC type move coming
👍️0
PonkenPlonken PonkenPlonken 2 meses hace
super super undervalued. Sid Mukherjee - gifted founder. Couple with recent clinical validation...
Problem in AML is not the drugs efficacy rather the possibility to handle the drug. They might just fix that.
👍️0
PonkenPlonken PonkenPlonken 2 meses hace
good dip buy
👍️0
PonkenPlonken PonkenPlonken 4 meses hace
The buyers of all these shares arent going anywhere. Waiting for it to unfold.
All the traders didnt understand this prudent PR? You dont need fluffy if you have the real deal
👍️0
PonkenPlonken PonkenPlonken 4 meses hace
remember this was founded to heal patients, not retire the management. This is a mission by the brilliant founder and the $$ will come as a by product of things being very right.
👍️0
PonkenPlonken PonkenPlonken 4 meses hace
Helps where CAR T cant in AML. Its about giving MORE of the drugs that heal..... they work but the body cant handle them. With VOR, it can.

People might just start realizing how huge the possibilities for this are.... GIVEN: r/r AML makes up 40-50% in younger patients and the great majority of elderly patients.
Now experiment with the 20bn TAM for r/r AML and some funny numbers start popping up.
Look at the founder... hes onto something.

the actual data will speak soon. The investigator is ultra optimistic.... he likely saw more.
👍️0
glenn1919 glenn1919 4 meses hace
VOR................................https://stockcharts.com/h-sc/ui?s=VOR&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 6 meses hace
VOR new 52 week low
👍️0
Monksdream Monksdream 6 meses hace
VOR new 52 week low
👍️0
PonkenPlonken PonkenPlonken 6 meses hace
Sid Mukherjee saw the potential in Saar Gills and Carl Junes approach and funded VOR==== shielding the right cells and attacking the cancer. For simplicity, it could be summed up as bottom up selectivity.................
Very different from all the other CAR T stuff out there that is pretty much top-down-y. And in my opinion, top down systems dont work.
5am and RA certainly think so. Will go back to the IPO price and then some is my bet.
👍️0
Monksdream Monksdream 6 meses hace
GNPX new 52 week low

👍️0
PonkenPlonken PonkenPlonken 6 meses hace
Im starting to think someone just buys them out.
Interesting action yesterday.
👍️0
Monksdream Monksdream 7 meses hace
VOR new 52 week low
👍️0
Monksdream Monksdream 7 meses hace
VOR new 52 week low
👍️0
PonkenPlonken PonkenPlonken 7 meses hace
elevated volume for quite some time now.
👍️0
PonkenPlonken PonkenPlonken 8 meses hace
https://en.wikipedia.org/wiki/Siddhartha_Mukherjee founder is a smart man. They can do Car T without the tox.
👍️0
Monksdream Monksdream 9 meses hace
VORBunder $2
👍️0
glenn1919 glenn1919 10 meses hace
VOR.....................................https://stockcharts.com/h-sc/ui?s=VOR&p=W&b=5&g=0&id=p86431144783
👍️0

Su Consulta Reciente

Delayed Upgrade Clock